Dissemin is shutting down on January 1st, 2025

Published in

Newlands Press, Future Medicinal Chemistry, 9(8), p. 931-947, 2016

DOI: 10.4155/fmc-2016-0033

Links

Tools

Export citation

Search in Google Scholar

Discovery of the first small-molecule CsrA–RNA interaction inhibitors using biophysical screening technologies

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Aim: CsrA is a global post-transcriptional regulator protein affecting mRNA translation and/or stability. Widespread among bacteria, it is essential for their full virulence and thus represents a promising anti-infective drug target. Therefore, we aimed at the discovery of CsrA–RNA interaction inhibitors. Results & methodology: We followed two strategies: a screening of small molecules (A) and an RNA ligand-based approach (B). Using surface plasmon resonance-based binding and fluorescence polarization-based competition assays, (A) yielded seven small-molecule inhibitors, among them MM14 (IC50 of 4 µM). (B) resulted in RNA-based inhibitor GGARNA (IC50 of 113 µM). Conclusion: The first small-molecule inhibitors of the CsrA–RNA interaction were discovered exhibiting micromolar affinities. These hits represent tools to investigate the effects of CsrA–RNA interaction inhibition on bacterial virulence.